Jon P. Stonehouse, President & CEO at BIOCRYST PHARMACEUTICALS INC (BCRX), bought 9,900 shares at $9.86 ($98K) on 2007-08-14, disclosed to the SEC on 2007-08-14.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.80 | 100 | $980 | 1.0% |
| 2 | $9.81 | 1,400 | $14K | 14.0% |
| 3 | $9.84 | 50 | $492 | 0.5% |
| 4 | $9.85 | 144 | $1K | 1.4% |
| 5 | $9.87 | 356 | $4K | 3.6% |
| 6 | $9.94 | 1,500 |
| $15K |
| 15.2% |
| 7 | $9.95 | 3,700 | $37K | 37.6% |
| 8 | $9.86 | 2,650 | $26K | 26.7% |
| Total | $9.90 avg | 9,900 | $98K | 100% |
| Filing → |
| BCRX | SELL | 2022-12-19 | $154K | — | Filing → |
| BCRX | SELL | 2022-12-02 | $4.9M | — | Filing → |
| BCRX | SELL | 2022-01-13 | $2.8M | — | Filing → |